ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Harvard Physician Whose Cancer Was Spread Through Morcellation Seeks to Revamp FDA Regulation of Medical Devices

July 4, 2014

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

R. Lee Clark to Retire; Texas Starts Search for Successor

September 9, 1977